Skip to content

Study · Measured the body's own peptide · 2009

1 result

Study of the human plasma proteome of rheumatoid arthritis.

Zheng X, Wu SL, Hincapie M, Hancock WS

Journal of chromatography. A24 Jan 2009Cited by 44 (Europe PMC)

PMID19215933 (opens in a new tab)DOI10.1016/j.chroma.2009.01.063 (opens in a new tab)PepBankPUB-19215933
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelObservational studyOther

    In plasma proteomics of patients with rheumatoid arthritis and controls, thymosin beta4 was newly identified as a protein linked to the disease.

    In plain wordsIn patients with rheumatoid arthritis, the body's own thymosin beta4 was newly found in plasma as a protein linked to the disease.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    Direction not reportedPlasma thymosin beta4 in rheumatoid arthritis
    Study

    n: not reported in source

    Outcome group
    Inflammation markers · Immune and inflammation

    Source sentences

    Summary
    While some of these proteins/peptides have been previously reported to be associated with RA disease such as calgranulin A, B, C and C-reactive protein, several others were newly identified (such as thymosin beta4, actin, tubulin, and vimentin), which may further the understanding of the disease pathogenesis.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.